MY142256A - Compositions and methods for topical diagnostic and therapeutic transport - Google Patents

Compositions and methods for topical diagnostic and therapeutic transport

Info

Publication number
MY142256A
MY142256A MYPI20064148A MY142256A MY 142256 A MY142256 A MY 142256A MY PI20064148 A MYPI20064148 A MY PI20064148A MY 142256 A MY142256 A MY 142256A
Authority
MY
Malaysia
Prior art keywords
compositions
methods
delivery
topical
diagnostic
Prior art date
Application number
Inventor
Michael D Dake
Jacob M Waugh
Original Assignee
Revance Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revance Therapeutics Inc filed Critical Revance Therapeutics Inc
Priority to MYPI20064148 priority Critical patent/MY142256A/en
Publication of MY142256A publication Critical patent/MY142256A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSITIONS AND METHODS ARE PROVIDED THAT ARE USEFUL FOR THE DELIVERY, INCLUDING TRANSDERMAL DELIVERY, OF BIOLOGICALLY ACTIVE AGENTS, SUCH AS NON-PROTEIN NON-NUCLEOTIDE THERAPEUTICS AND PROTEIN-BASED THERAPEUTICS EXCLUDING INSULIN, BOTULINUM TOXINS, ANTIBODY FRAGMENTS, AND VEGF. THE COMPOSITIONS AND METHODS ARE PARTICULARLY USEFUL FOR TOPICAL DELIVERY OF ANTIFUNGAL AGENTS AND ANTIGENIC AGENTS SUITABLE FOR IMMUNIZATION. ALTERNATELY, THE COMPOSITIONS CAN BE PREPARED WITH COMPONENTS USEFUL FOR TARGETING THE DELIVERY OF THE COMPOSITIONS AS WELL AS IMAGING COMPONENTS.
MYPI20064148 2006-09-14 2006-09-14 Compositions and methods for topical diagnostic and therapeutic transport MY142256A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20064148 MY142256A (en) 2006-09-14 2006-09-14 Compositions and methods for topical diagnostic and therapeutic transport

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20064148 MY142256A (en) 2006-09-14 2006-09-14 Compositions and methods for topical diagnostic and therapeutic transport

Publications (1)

Publication Number Publication Date
MY142256A true MY142256A (en) 2010-11-15

Family

ID=47320801

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20064148 MY142256A (en) 2006-09-14 2006-09-14 Compositions and methods for topical diagnostic and therapeutic transport

Country Status (1)

Country Link
MY (1) MY142256A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11332518B2 (en) 2008-03-14 2022-05-17 Allergan, Inc. Immuno-based botulinum toxin serotype A activity assays

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11332518B2 (en) 2008-03-14 2022-05-17 Allergan, Inc. Immuno-based botulinum toxin serotype A activity assays

Similar Documents

Publication Publication Date Title
SG150570A1 (en) Compositions and methods for topical diagnostic and therapeutic transport
SG150569A1 (en) Multi-component biological transport systems
MX344727B (en) IMPROVED HIGH CONCENTRATION ANTI-TNFa ANTIBODY LIQUID FORMULATIONS.
MX2009012343A (en) Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto.
CY1118153T1 (en) TREATMENT OF MICROBIAL INFECTIONS
WO2009126292A3 (en) Biologically active peptidomimetic macrocycles
NZ711373A (en) Fragments of p97 and uses thereof
TN2014000148A1 (en) Antigen binding protein and its use as addressing product for the treatment of cancer
MX2016002152A (en) Method for increasing expression of rna-encoded proteins.
MX359449B (en) Anti-cd70 antibody drug conjugates.
AU2018256498A1 (en) Antibodies to amyloid beta
MX2012010114A (en) Concentrated protein formulations and uses thereof.
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
MX357193B (en) Anti-alpha synuclein binding molecules.
MX358013B (en) Material and methods for treating or preventing her-3 associated diseases.
TN2011000229A1 (en) Antibody formulation
ECSP088962A (en) NEW HERBICIDES
WO2012064792A3 (en) Protein complexes for antigen binding and methods of use
MX2013007067A (en) Anti-il-18 antibodies and their uses.
MX2009007691A (en) Pegylated aî² fab.
MX2013015324A (en) Wap domain fusion polypeptides and methods of use thereof.
MA32288B1 (en) New antibodies useful for cancer treatment
WO2008085987A3 (en) Drug delivery to human tissues by single chain variable region antibody fragments cloned by phage display
WO2014204988A3 (en) 5t4-targeted immunofusion molecule and methods
EA201491369A1 (en) METHOD OF TREATING DIABETES MELLITUS WITH NON-GLYCOLYNED APOLYPOPROTEIN A-IV